Aspargo Labs, Inc. (AAGO)

Aspargo Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	18.72	9.74	0.11
Cash & Cash Equivalents	18.72	9.74	0.11
Cash Growth	-	8372.77%	-
Receivables	0.25	-	0
Total Current Assets	18.97	9.74	0.12
Property, Plant & Equipment	-	0.31	0.18
Goodwill and Intangibles	-	1.55	1.41
Other Long-Term Assets	-	0	-0
Total Long-Term Assets	-	1.87	1.59
Total Assets	-	11.6	1.71
Accounts Payable	-	1.49	0.42
Current Debt	-	0.15	0.98
Other Current Liabilities	2.07	0.35	2.65
Total Current Liabilities	2.07	1.99	4.05
Long-Term Debt	-	0.06	-
Other Long-Term Liabilities	-	1.5	0
Total Long-Term Liabilities	-	1.56	0
Total Liabilities	-	3.55	4.05
Total Debt	0.11	0.21	0.98
Debt Growth	-	-78.71%	-
Retained Earnings	-	-29.98	-15.59
Comprehensive Income	-	0.01	0.01
Shareholders' Equity	17.15	8.06	-2.34
Net Cash / Debt	18.62	9.53	-0.87
Working Capital	-3.93	7.75	-3.93

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).